Embolotherapy Market by Product, Disease Indication, Procedure, End-User - Global Forecast 2025-2030- Product Image

Sale

Embolotherapy Market by Product, Disease Indication, Procedure, End-User - Global Forecast 2025-2030

Report
181 Pages
October 2024
Region: Global
360iResearch™
ID: 4829978

UP TO €692EUR$697USD£574GBP OFF until Dec 31^st 2024

The Embolotherapy Market grew from USD 4.40 billion in 2023 to USD 4.79 billion in 2024. It is expected to continue growing at a CAGR of 8.91%, reaching USD 8.00 billion by 2030.

Embolotherapy is an interventional procedure utilized to block blood flow to a specific part of the body, often to treat tumors, hemorrhages, or vascular malformations. Its necessity is underscored by its minimally invasive nature compared to surgical alternatives, offering reduced recovery times and fewer complications. The application of embolotherapy spans various medical fields including oncology, gynecology, and neurology, with end-use spread across hospitals, ambulatory surgical centers, and specialty clinics. The market is primarily driven by the rising incidence of cancer and bleeding disorders, technological advancements in imaging and catheter technologies, and an increased preference for minimally invasive procedures. The burgeoning demand for precise and targeted therapies is a major propellant, alongside increasing investments in healthcare infrastructure in emerging economies. Key growth opportunities lie in innovations like drug-eluting beads and microcatheters, and expanding applications in prostate and uterine treatments offer promising avenues. However, market growth is challenged by high procedure costs, stringent regulatory requirements, and a limited pool of skilled professionals, which can hinder the adoption of these technologies. To leverage emerging opportunities, businesses should focus on R&D to enhance device precision and efficacy, explore collaborations with healthcare providers for education and training, and expand geographical outreach especially in untapped markets in Asia-Pacific and Latin America. Best areas of innovation include the development of biodegradable embolic agents and AI-driven imaging solutions that enhance procedural accuracy. Market nature is dynamic and competitive, predominantly driven by innovation-centered companies striving to advance technological capabilities. Therefore, carving a niche in tech-driven enhancements and meeting the demand for cost-effective patient-centered solutions can catalyze growth in this sector.

Understanding Market Dynamics in the Embolotherapy Market

The Embolotherapy Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Increasing target patient population
- Investment & funding by government and private organizations
- Favorable reimbursement scenario for minimally invasive surgeries
Market Restraints
- Lack of sufficient evidence & unfavorable regulatory scenario
Market Opportunities
- Growth opportunities in emerging markets
- Expanding applications of embolization devices
Market Challenges
- Lack of skilled surgeons
- High cost and resulting difficulties in accessing embolization in developing countries

Exploring Porter’s Five Forces for the Embolotherapy Market

Porter’s Five Forces framework further strengthens the insights of the Embolotherapy Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Embolotherapy Market

External macro-environmental factors deeply influence the performance of the Embolotherapy Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Embolotherapy Market

The Embolotherapy Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Embolotherapy Market

The Embolotherapy Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Embolotherapy Market

The Embolotherapy Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Embolotherapy Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acandis GmbH, Balt Extrusion, Boston Scientific Corporation, Cook Medical Incorporated, Guerbet, Johnson & Johnson Services, Inc., Kaneka Corporation, Medtronic PLC, Meril Life Sciences Pvt., Ltd., Merit Medical Systems Inc., Penumbra, Inc., Sirtex Medical Limited, Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Embolotherapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Embolic Agents
  - Detachable Balloons
  - Embolic Coils
  - Embolic Plug Systems
  - Liquid Embolic Agents
  - Microspheres
- Support Devices
  - Guidewires
  - Microcatheters
Disease Indication
- Cancer
- Gastrointestinal Disorders
- Neurological Diseases
- Peripheral Vascular Disease
- Urological & Nephrological Disorders
Procedure
- Transarterial Chemoembolization
- Transcatheter Arterial Embolization
- Transcatheter Arterial Radioembolization & Selective Internal Radiation Therapy
End-User
- Ambulatory Surgery Centers
- Hospitals & Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Embolotherapy Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing target patient population
5.1.1.2. Investment & funding by government and private organizations
5.1.1.3. Favorable reimbursement scenario for minimally invasive surgeries
5.1.2. Restraints
5.1.2.1. Lack of sufficient evidence & unfavorable regulatory scenario
5.1.3. Opportunities
5.1.3.1. Growth opportunities in emerging markets
5.1.3.2. Expanding applications of embolization devices
5.1.4. Challenges
5.1.4.1. Lack of skilled surgeons
5.1.4.2. High cost and resulting difficulties in accessing embolization in developing countries
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Embolotherapy Market, by Product

6.1. Introduction
6.2. Embolic Agents
6.3.1. Detachable Balloons
6.3.2. Embolic Coils
6.3.3. Embolic Plug Systems
6.3.4. Liquid Embolic Agents
6.3.5. Microspheres
6.3. Support Devices
6.4.1. Guidewires
6.4.2. Microcatheters

7. Embolotherapy Market, by Disease Indication

7.1. Introduction
7.2. Cancer
7.3. Gastrointestinal Disorders
7.4. Neurological Diseases
7.5. Peripheral Vascular Disease
7.6. Urological & Nephrological Disorders

8. Embolotherapy Market, by Procedure

8.1. Introduction
8.2. Transarterial Chemoembolization
8.3. Transcatheter Arterial Embolization
8.4. Transcatheter Arterial Radioembolization & Selective Internal Radiation Therapy

9. Embolotherapy Market, by End-User

9.1. Introduction
9.2. Ambulatory Surgery Centers
9.3. Hospitals & Clinics

10. Americas Embolotherapy Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Embolotherapy Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Embolotherapy Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. Acandis GmbH
14.1.3. Balt Extrusion
14.1.4. Boston Scientific Corporation
14.1.5. Cook Medical Incorporated
14.1.6. Guerbet
14.1.7. Johnson & Johnson Services, Inc.
14.1.8. Kaneka Corporation
14.1.9. Medtronic PLC
14.1.10. Meril Life Sciences Pvt., Ltd.
14.1.11. Merit Medical Systems Inc.
14.1.12. Penumbra, Inc.
14.1.13. Sirtex Medical Limited
14.1.14. Stryker Corporation
14.1.15. Terumo Corporation
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. EMBOLOTHERAPY MARKET RESEARCH PROCESS
FIGURE 2. EMBOLOTHERAPY MARKET SIZE, 2023 VS 2030
FIGURE 3. EMBOLOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. EMBOLOTHERAPY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. EMBOLOTHERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. EMBOLOTHERAPY MARKET DYNAMICS
FIGURE 7. EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
FIGURE 10. EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2023 VS 2030 (%)
FIGURE 12. EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EMBOLOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. EMBOLOTHERAPY MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. EMBOLOTHERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. EMBOLOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 8. EMBOLOTHERAPY MARKET SIZE, BY DETACHABLE BALLOONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC PLUG SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. EMBOLOTHERAPY MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 15. EMBOLOTHERAPY MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. EMBOLOTHERAPY MARKET SIZE, BY MICROCATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 18. EMBOLOTHERAPY MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. EMBOLOTHERAPY MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. EMBOLOTHERAPY MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. EMBOLOTHERAPY MARKET SIZE, BY UROLOGICAL & NEPHROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 24. EMBOLOTHERAPY MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. EMBOLOTHERAPY MARKET SIZE, BY TRANSCATHETER ARTERIAL EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. EMBOLOTHERAPY MARKET SIZE, BY TRANSCATHETER ARTERIAL RADIOEMBOLIZATION & SELECTIVE INTERNAL RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. EMBOLOTHERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. EMBOLOTHERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. CANADA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. CANADA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 51. CANADA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 52. CANADA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 53. CANADA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 54. CANADA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. MEXICO EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. MEXICO EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 57. MEXICO EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 58. MEXICO EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 59. MEXICO EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 60. MEXICO EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. CHINA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. CHINA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 83. CHINA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 84. CHINA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 85. CHINA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 86. CHINA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. INDIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. INDIA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 89. INDIA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 90. INDIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 91. INDIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 92. INDIA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. JAPAN EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. JAPAN EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 101. JAPAN EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 102. JAPAN EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 103. JAPAN EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 104. JAPAN EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. THAILAND EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. THAILAND EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 137. THAILAND EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 138. THAILAND EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 139. THAILAND EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 140. THAILAND EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 154. DENMARK EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. DENMARK EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 156. DENMARK EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 157. DENMARK EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 158. DENMARK EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 159. DENMARK EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. EGYPT EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. EGYPT EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 162. EGYPT EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 163. EGYPT EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 164. EGYPT EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 165. EGYPT EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. FINLAND EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. FINLAND EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 168. FINLAND EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 169. FINLAND EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 170. FINLAND EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 171. FINLAND EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. FRANCE EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. FRANCE EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 174. FRANCE EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 175. FRANCE EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 176. FRANCE EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 177. FRANCE EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. GERMANY EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. GERMANY EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 180. GERMANY EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 181. GERMANY EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 182. GERMANY EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 183. GERMANY EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. ITALY EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. ITALY EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 192. ITALY EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 193. ITALY EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 194. ITALY EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 195. ITALY EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 208. NORWAY EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 209. NORWAY EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 210. NORWAY EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 211. NORWAY EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 212. NORWAY EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 213. NORWAY EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. POLAND EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 215. POLAND EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 216. POLAND EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 217. POLAND EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 218. POLAND EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 219. POLAND EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 220. QATAR EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 221. QATAR EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 222. QATAR EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 223. QATAR EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 224. QATAR EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 225. QATAR EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 244. SPAIN EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 245. SPAIN EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 246. SPAIN EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 247. SPAIN EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 248. SPAIN EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 249. SPAIN EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 262. TURKEY EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 263. TURKEY EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 264. TURKEY EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 265. TURKEY EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 266. TURKEY EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 267. TURKEY EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 280. EMBOLOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 281. EMBOLOTHERAPY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 282. EMBOLOTHERAPY MARKET LICENSE & PRICING

Companies Mentioned

The leading players in the Embolotherapy Market, which are profiled in this report, include:

Abbott Laboratories
Acandis GmbH
Balt Extrusion
Boston Scientific Corporation
Cook Medical Incorporated
Guerbet
Johnson & Johnson Services, Inc.
Kaneka Corporation
Medtronic PLC
Meril Life Sciences Pvt., Ltd.
Merit Medical Systems Inc.
Penumbra, Inc.
Sirtex Medical Limited
Stryker Corporation
Terumo Corporation

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	181
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 4.79 Billion
Forecasted Market Value ( USD ) by 2030	$ 8 Billion
Compound Annual Growth Rate	8.9%
Regions Covered	Global
No. of Companies Mentioned	16

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3518EUR$3,545USD£2,919GBP €3909EUR$3,939USD£3,243GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6224EUR$6,272USD£5,164GBP €6915EUR$6,969USD£5,738GBP

Understanding Market Dynamics in the Embolotherapy Market

Exploring Porter’s Five Forces for the Embolotherapy Market

Applying PESTLE Analysis to the Embolotherapy Market

Analyzing Market Share in the Embolotherapy Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Embolotherapy Market

Strategic Recommendations for Success in the Embolotherapy Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Embolotherapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - (By Product Type Coverage, Cancer Indication Coverage, Procedure Coverage, End User Coverage, Geographic Coverage and By Company)

Embolotherapy - Global Strategic Business Report

Embolotherapy - Market Insight, Epidemiology and Market Forecast - 2034

Embolotherapy Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

Transcatheter Embolization & Occlusion Device Market by Product, Application, End User - Global Forecast 2025-2030

About the Embolotherapy Market